Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 15, 2016

Drug Name	Review Type	Class	Manufacturer
Dyanavel XR Susp.	New Drug Initial Review	Stimulants	Tris Pharma, Inc.
Viberzi	New Drug Initial Review	Irritable Bowel with diarrhea	Allergan
Xeljanz	New Drug Appeal	Rheumatoid Arthritis	Pfizer
Xeljanz XR	New Drug Appeal	Rheumatoid Arthritis	Pfizer
Savaysa	New Drug Appeal	NOAC Anti-Coagulant	Daiichi Sankyo
Orenitram	New Drug Appeal	Pulmonary Arterial Hypertension	United Therapeutics
Brilinta	PDL Appeal	Platelet Aggregation Inhibitor	AstraZeneca

Class